Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-206.69%Operating Cash Flow Margin
VS
Market
Sector
Industry
History
$ 1.77Close
$ 0.39 - $ 1.79 52-Week Range
Ticker Information
Ticker
LCTXCompany Name
LINEAGE CELL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTLINEAGE CELL THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LCTX - OCF % Historical data
| Date | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -22.56M | -206.69% | $ 10.91M |
| 3/31/2025 | $ -22.2M | -232.24% | $ 9.56M |
| 12/31/2024 | $ -23.09M | -243.1% | $ 9.5M |
| 9/30/2024 | $ -22.77M | -261.1% | $ 8.72M |
| 6/30/2024 | $ -22.02M | -355.88% | $ 6.19M |
| 3/31/2024 | $ -23.11M | -288.73% | $ 8M |
| 12/31/2023 | $ -28.57M | -319.35% | $ 8.95M |
| 9/30/2023 | $ -30.85M | -351.69% | $ 8.77M |
| 6/30/2023 | $ -31.29M | -297.35% | $ 10.52M |
| 3/31/2023 | $ -32.09M | -270.73% | $ 11.85M |
Key Performance Insights, Last 5 Years
- LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -724%.
- Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average OCF % has been -414.33%.
- The median OCF % for LINEAGE CELL THERAPEUTICS INC during this period was -293.04%
- LINEAGE CELL THERAPEUTICS INC reached its highest OCF % over the past 5 years at 62.77%.
- The lowest OCF % recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe -1300.7%
LINEAGE CELL THERAPEUTICS INC's OCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
OCF % Benchmarks
Similar metrics to Revenues:
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Operating Cash Flow Margin
[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].CF - Operations / Revenues
(=) OCF % OCF % for LINEAGE CELL THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -19.64M ] / Revenues [ $ 2.71M ]
(=) OCF % [ -724% ] LCTX - Operating Cash Flow Margin, Last 5 years
-1300.7%
Minimum
Mar 31, 2021
62.77%
Maximum
Mar 31, 2022
-414.33%
Average
-293.04%
Median
OCF % Benchmark AnalysisMarket
The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.36% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | -57.27% |
| max | 78.12% |
| average | 14.36% |
| median | 12.67% |
| std | 21.14% |